Venclexta and Polyuria - a phase IV clinical study of FDA data

Summary:

Polyuria is reported as a side effect among people who take Venclexta (venetoclax), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Famvir, and have Acute biphenotypic leukaemia.

The phase IV clinical study analyzes which people have Polyuria when taking Venclexta. It is created by eHealthMe based on reports of 31,417 people who have side effects when taking Venclexta from the FDA, and is updated regularly.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

What is Polyuria?

Polyuria (production of too much dilute urine) is found to be associated with 1,611 drugs and 1,286 conditions by eHealthMe. Check the latest studies of Polyuria.

On Jun, 22, 2026

31,417 people reported to have side effects when taking Venclexta.
Among them, 6 people (0.02%) have Polyuria.

Among these 6 people:

How long have people been on Venclexta when they have Polyuria? *

What is the gender of people who have Polyuria when taking Venclexta? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Polyuria when taking Venclexta? *

What are other drugs people take besides Venclexta? *

What are other side effects people have besides Polyuria? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 50.00%
Blood Creatinine Increased: 2 people, 33.33%
Thrombocytopenia (decrease of platelets in blood): 2 people, 33.33%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 2 people, 33.33%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 33.33%
Tumor Lysis Syndrome: 2 people, 33.33%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 33.33%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 33.33%
Pneumonia: 2 people, 33.33%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 1 person, 16.67%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 33.33%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 33.33%
Acute Biphenotypic Leukaemia (leukaemia where the lineage is of both lymphoid and myeloid origin): 2 people, 33.33%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 16.67%
Tumor: 1 person, 16.67%
Stomatitis (inflammation of mucous membrane of mouth): 1 person, 16.67%
Nosebleed (bleeding from nose): 1 person, 16.67%
Nausea (feeling of having an urge to vomit): 1 person, 16.67%
Nasopharyngeal Cancer (cancer of nasopharynx): 1 person, 16.67%
Mouth Ulcers: 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Venclexta and have Polyuria?

- Check whether Polyuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Venclexta:

Venclexta (31,425 reports)

Polyuria treatments and more:

Polyuria (15,800 reports)

Browse all side effects of Venclexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Polyuria:

Polyuria (1,611 drugs)

Browse all the conditions that are associated with Polyuria:

Polyuria (1,286 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on venetoclax (the active ingredients of Venclexta) and Venclexta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.